METABOLIC SOLUTIONS DEV CO LLC has a total of 79 patent applications. Its first patent ever was published in 2007. It filed its patents most often in EPO (European Patent Office), Canada and Republic of Korea. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and measurement are DOGWOOD PHARMACEUTICALS INC, ATON PHARMA INC and PHARMACIA CORP.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 12 | |
#2 | Canada | 11 | |
#3 | Republic of Korea | 10 | |
#4 | Mexico | 9 | |
#5 | WIPO (World Intellectual Property Organization) | 9 | |
#6 | United States | 7 | |
#7 | New Zealand | 6 | |
#8 | China | 4 | |
#9 | Hong Kong | 3 | |
#10 | Hungary | 3 | |
#11 | Israel | 2 | |
#12 | Japan | 2 | |
#13 | Russian Federation | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Measurement |
# | Name | Total Patents |
---|---|---|
#1 | Tanis Steven P | 55 |
#2 | Larsen Scott D | 48 |
#3 | Colca Gerard R | 43 |
#4 | Parker Timothy | 37 |
#5 | Kletzien Rolf F | 30 |
#6 | Gadwood Robert C | 25 |
#7 | Zeller James R | 24 |
#8 | Artman Gerald D Iii | 16 |
#9 | Artman Iii Gerald D | 3 |
#10 | Artman Gerald D | 3 |
Publication | Filing date | Title |
---|---|---|
KR20160033741A | Ppar-sparing compounds for the treatment of metabolic diseases | |
WO2012178142A1 | Ppar-sparing compounds and combinations fort the treatment of diabetes and other metabolic diseases | |
WO2012149083A1 | Ppar-sparing thiazolidinediones for the treatment of kidney related diseases | |
WO2012109495A1 | Cellular targets of thiazolidinediones | |
CA2807815A1 | Novel synthesis for thiazolidinedione compounds | |
WO2012021476A1 | Novel synthesis for thiazolidinedione compounds | |
WO2011133441A2 | Novel synthesis for thiazolidinedione compounds | |
NZ602883A | Novel synthesis for thiazolidinedione compounds | |
EP2512471A1 | Ppar-sparing thiazolidinediones and combinations for the treatment of diabetes mellitus and other metabolic diseases | |
CA2783262A1 | Ppar-sparing thiazolidinediones and combinations for the treatment of obesity and other metabolic diseases | |
EP2001469A2 | Thiazolidinedione analogues |